6.05
price down icon4.42%   -0.28
after-market アフターアワーズ: 6.10 0.05 +0.83%
loading
前日終値:
$6.33
開ける:
$6.32
24時間の取引高:
1.08M
Relative Volume:
0.89
時価総額:
$328.39M
収益:
$1.02B
当期純損益:
$-757.20M
株価収益率:
-0.4099
EPS:
-14.76
ネットキャッシュフロー:
$-257.90M
1週間 パフォーマンス:
-6.35%
1か月 パフォーマンス:
+22.22%
6か月 パフォーマンス:
-33.88%
1年 パフォーマンス:
-9.30%
1日の値動き範囲:
Value
$6.01
$6.32
1週間の範囲:
Value
$6.01
$6.62
52週間の値動き範囲:
Value
$4.02
$15.10

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
名前
Emergent Biosolutions Inc
Name
セクター
Healthcare (1168)
Name
電話
240-631-3200
Name
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
職員
900
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
EBS's Discussions on Twitter

EBS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
6.05 350.63M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.12 50.98B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.61 74.41B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.93 4.03M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.99 46.23B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.25 20.10B 16.54B -1.64B 749.00M -1.45

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-30 開始されました H.C. Wainwright Buy
2024-08-22 開始されました Rodman & Renshaw Buy
2024-03-07 アップグレード The Benchmark Company Hold → Buy
2023-11-20 再開されました JP Morgan Underweight
2023-08-29 ダウングレード The Benchmark Company Buy → Hold
2023-04-10 アップグレード The Benchmark Company Hold → Buy
2023-03-17 ダウングレード JP Morgan Neutral → Underweight
2022-11-10 ダウングレード The Benchmark Company Buy → Hold
2022-04-29 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-01-20 アップグレード The Benchmark Company Hold → Buy
2021-11-08 ダウングレード The Benchmark Company Buy → Hold
2021-05-05 ダウングレード Argus Buy → Hold
2021-04-07 開始されました The Benchmark Company Buy
2021-02-24 アップグレード Chardan Capital Markets Neutral → Buy
2021-02-19 ダウングレード Chardan Capital Markets Buy → Neutral
2021-01-08 ダウングレード Wells Fargo Overweight → Equal Weight
2020-09-14 再開されました JP Morgan Neutral
2020-07-31 繰り返されました Chardan Capital Markets Buy
2019-09-12 開始されました Guggenheim Buy
2019-09-04 アップグレード Wells Fargo Market Perform → Outperform
2018-11-02 アップグレード Goldman Neutral → Buy
2018-08-03 繰り返されました Chardan Capital Markets Buy
2018-06-13 開始されました Argus Buy
2018-04-25 ダウングレード Wells Fargo Outperform → Market Perform
2018-01-24 開始されました Goldman Neutral
2018-01-16 繰り返されました Chardan Capital Markets Buy
2016-06-28 繰り返されました Singular Research Buy
2016-04-15 開始されました Chardan Capital Markets Buy
2016-03-28 開始されました Singular Research Buy
2016-02-19 開始されました Wells Fargo Outperform
2014-05-15 開始されました Summer Street Research Buy
2011-05-31 繰り返されました WBB Securities Strong Buy
2011-01-10 繰り返されました Wedbush Outperform
2010-11-05 繰り返されました Wedbush Outperform
2010-08-18 アップグレード WBB Securities Buy → Strong Buy
2010-08-06 繰り返されました Caris & Company Buy
すべてを表示

Emergent Biosolutions Inc (EBS) 最新ニュース

pulisher
05:28 AM

Emergent BioSolutions at Jefferies Conference: Strategic Transformation By Investing.com - Investing.com Canada

05:28 AM
pulisher
07:31 AM

Emergent BioSolutions (EBS) Partners with Foundation for Opioid Awareness | EBS Stock News - GuruFocus

07:31 AM
pulisher
07:29 AM

Emergent BioSolutions Supports Victoria's Voice Foundation's Nat - GuruFocus

07:29 AM
pulisher
07:00 AM

Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access - Stock Titan

07:00 AM
pulisher
Jun 03, 2025

Vaccine Contract Manufacturing Market Set to Witness - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Biodefense Market Set to Witness Significant GrowthEmergent BioSolutions Inc., SIGA Technologies - openPR.com

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Boosts Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 3,692 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

May 28, 2025
pulisher
May 26, 2025

Emergent BioSolutions discloses CEO stock purchase - MSN

May 26, 2025
pulisher
May 23, 2025

Emergent Biosolutions Settlement Receives Preliminary Approval - TipRanks

May 23, 2025
pulisher
May 19, 2025

Emergent BioSolutions ($EBS) Is Paying a $40M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 19, 2025
pulisher
May 19, 2025

Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

Q1 EPS Forecast for Emergent BioSolutions Lowered by Analyst - Defense World

May 18, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge 9.7% Following Positive Developments | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) CEO Increases Stake with $350,000 Sh - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock Ne - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock Ne - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions stock up on insider purchase (EBS:NYSE) - Seeking Alpha

May 16, 2025
pulisher
May 16, 2025

Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent B - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Emergent BioSolutions to Participate in Upcoming Investor Conferences | EBS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Emergent BioSolutions to Participate in Upcoming Investor Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Emergent BioSolutions Lines Up 4 Major Wall Street Conferences: RBC, Goldman Sachs, Jefferies Featured - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Sells 11,665 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

May 13, 2025
pulisher
May 11, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st

May 11, 2025
pulisher
May 09, 2025

Emergent BioSolutions (EBS) Q1 2025 Earnings Highlight Turnaroun - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Emergent Biosolutions Q1 2025 Earnings Preview - MSN

May 09, 2025
pulisher
May 09, 2025

Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN

May 08, 2025
pulisher
May 08, 2025

Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress - MSN

May 08, 2025
pulisher
May 08, 2025

Emergent Biosolutions: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - Yahoo

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid Revenue Challenges - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Emergent Biosolutions earnings beat by $0.22, revenue fell short of estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Emergent BioSolutions Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Emergent BioSolutions (EBS) Updates 2025 Financial Forecast | EBS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Emergent BioSolutions (EBS) Reports Strong Q1 Revenue | EBS Stoc - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Emergent BioSolutions Reports 656% Net Income Surge - TipRanks

May 07, 2025
pulisher
May 07, 2025

Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability - Investing.com

May 07, 2025

Emergent Biosolutions Inc (EBS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$8.46
price down icon 1.51%
$124.61
price up icon 0.07%
drug_manufacturers_specialty_generic RDY
$15.53
price up icon 5.29%
drug_manufacturers_specialty_generic HCM
$15.26
price down icon 0.26%
$319.71
price down icon 1.31%
$17.25
price down icon 1.54%
大文字化:     |  ボリューム (24 時間):